These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21813381)

  • 1. Prognostic role of diabetes mellitus in hepatocellular carcinoma patients after curative treatments: a meta-analysis.
    Wang WM; Xu Y; Yang XR; Wang YH; Sun HX; Fan J
    Hepatobiliary Pancreat Dis Int; 2011 Aug; 10(4):346-55. PubMed ID: 21813381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation.
    Zhang Q; Deng YL; Liu C; Huang LH; Shang L; Chen XG; Wang LT; Du JZ; Wang Y; Wang PX; Zhang H; Shen ZY
    World J Gastroenterol; 2016 Nov; 22(43):9571-9585. PubMed ID: 27920478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of adjuvant interferon therapy on hepatitis b/c virus-related hepatocellular carcinoma after curative therapy - meta-analysis.
    Xu J; Li J; Chen J; Liu ZJ
    Adv Clin Exp Med; 2015; 24(2):331-40. PubMed ID: 25931368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Features and Outcome of Surgical Patients with Non-B Non-C Hepatocellular Carcinoma.
    Wakiyama S; Matsumoto M; Haruki K; Gocho T; Sakamoto T; Shiba H; Futagawa Y; Ishida Y; Yanaga K
    Anticancer Res; 2017 Jun; 37(6):3207-3213. PubMed ID: 28551666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of prognosis by viral etiology in patients with hepatocellular carcinoma after radiofrequency ablation.
    Chen PH; Kao WY; Chiou YY; Hung HH; Su CW; Chou YH; Huo TI; Huang YH; Wu WC; Chao Y; Lin HC; Wu JC
    Ann Hepatol; 2013; 12(2):263-73. PubMed ID: 23396738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis.
    Tian X; Dai Y; Wang DQ; Zhang L; Sui CG; Meng FD; Jiang SY; Liu YP; Jiang YH
    Drug Des Devel Ther; 2015; 9():4431-40. PubMed ID: 26309396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes mellitus is a recurrence-independent risk factor in patients with hepatitis B virus-related hepatocellular carcinoma undergoing resection.
    Huo TI; Wu JC; Lui WY; Lee PC; Huang YH; Chau GY; Tsay SH; Chang FY; Lee SD
    Eur J Gastroenterol Hepatol; 2003 Nov; 15(11):1203-8. PubMed ID: 14560154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma.
    Jin YJ; Shim JH; Lee HC; Yoo DJ; Kim KM; Lim YS; Suh DJ
    J Gastroenterol Hepatol; 2011 Sep; 26(9):1380-8. PubMed ID: 21884247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes after curative treatment for cryptogenic cirrhosis-associated hepatocellular carcinoma satisfying the Milan criteria.
    Takuma Y; Nouso K; Makino Y; Gotoh T; Toshikuni N; Morimoto Y; Shimomura H; Yamamoto H
    J Gastroenterol Hepatol; 2011 Sep; 26(9):1417-24. PubMed ID: 21884248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma.
    Cabibbo G; Petta S; Barbàra M; Missale G; Virdone R; Caturelli E; Piscaglia F; Morisco F; Colecchia A; Farinati F; Giannini E; Trevisani F; Craxì A; Colombo M; Cammà C;
    Liver Int; 2017 Aug; 37(8):1157-1166. PubMed ID: 28061016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
    Lee S; Rhim H; Kim YS; Kang TW; Song KD
    Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes mellitus and poorer prognosis in hepatocellular carcinoma: a systematic review and meta-analysis.
    Wang YG; Wang P; Wang B; Fu ZJ; Zhao WJ; Yan SL
    PLoS One; 2014; 9(5):e95485. PubMed ID: 24830459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes Mellitus and/or Nonalcoholic Steatohepatitis-related Hepatocellular Carcinoma Showed Favorable Surgical Outcomes After Hepatectomy.
    Liang J; Ariizumi SI; Nakano M; Yamamoto M
    Anticancer Res; 2019 Oct; 39(10):5639-5643. PubMed ID: 31570461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal trends in disease presentation and survival of patients with hepatocellular carcinoma: A real-world experience from 1998 to 2015.
    Kim NG; Nguyen PP; Dang H; Kumari R; Garcia G; Esquivel CO; Nguyen MH
    Cancer; 2018 Jun; 124(12):2588-2598. PubMed ID: 29624631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular Carcinoma.
    Ikeda K; Kawamura Y; Kobayashi M; Kominami Y; Fujiyama S; Sezaki H; Hosaka T; Akuta N; Saitoh S; Suzuki F; Suzuki Y; Arase Y; Kumada H
    Dig Dis Sci; 2017 Oct; 62(10):2932-2942. PubMed ID: 28884320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Survival Impact of Diabetes Mellitus on Hepatocellular Carcinoma: Role of Staging Determinants.
    Ho SY; Yuan MH; Chen CC; Liu PH; Hsu CY; Huang YH; Lei HJ; Lee RC; Huo TI
    Dig Dis Sci; 2020 Nov; 65(11):3389-3402. PubMed ID: 31955286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma.
    Shau WY; Shao YY; Yeh YC; Lin ZZ; Kuo R; Hsu CH; Hsu C; Cheng AL; Lai MS
    Oncologist; 2012; 17(6):856-62. PubMed ID: 22622151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in hepatitis C patients with a single small hepatocellular carcinoma after radiofrequency ablation.
    Toshikuni N; Takuma Y; Goto T; Yamamoto H
    Hepatogastroenterology; 2012; 59(120):2361-6. PubMed ID: 23169175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between smoking habit and surgical outcomes on viral-associated hepatocellular carcinomas.
    Kai K; Komukai S; Koga H; Yamaji K; Ide T; Kawaguchi A; Aishima S; Noshiro H
    World J Gastroenterol; 2018 Jan; 24(1):58-68. PubMed ID: 29358882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination PEG-IFN a-2b/ribavirin therapy following treatment of hepatitis C virus-associated hepatocellular carcinoma is capable of improving hepatic functional reserve and survival.
    Ishikawa T; Higuchi K; Kubota T; Seki K; Honma T; Yoshida T; Kamimura T
    Hepatogastroenterology; 2012; 59(114):529-32. PubMed ID: 22024226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.